Methods of converting a fluorinated compound into a fluorinated acyl fluoride or derivative thereof, the method including reacting the fluorinated compound with a catalytic amount of at least one transition metal compound and an oxygen-containing compound to form the fluorinated acyl fluoride or derivative thereof. Compounds formed using such methods are also included, including for example <Insert chemical formulas here as they appear in the electronic copy.> and derivatives thereof, or combinations thereof.

##STR00001##

Methods of converting a fluorinated compound into a fluorinated acyl fluoride or derivative thereof, the method including reacting the fluorinated compound with a catalytic amount of at least one transition metal compound and an oxygen-containing compound to form the fluorinated acyl fluoride or derivative thereof. Compounds formed using such methods are also included, including for example <Insert chemical formulas here as they appear in the electronic copy.> and derivatives thereof, or combinations thereof.

##STR00001##

A method for the manufacture of perfluorinated compounds is herein disclosed. In particular, the method is useful for the manufacture of perfluorooxyalkyl carboxylic acid salts which can be used as surfactants. The method envisages the fluorination or a fluoroformate of an alcohol comprising a CH.sub.2OCH.sub.2-moiety at a temperature equal to or higher than 20 C. and allows obtaining high yields and selectivity.

A method for the manufacture of perfluorinated compounds is herein disclosed. In particular, the method is useful for the manufacture of perfluorooxyalkyl carboxylic acid salts which can be used as surfactants. The method envisages the fluorination or a fluoroformate of an alcohol comprising a CH.sub.2OCH.sub.2-moiety at a temperature equal to or higher than 20 C. and allows obtaining high yields and selectivity.

Provided are methods for removing a perfluorinated alkanoic acid from solutions containing the perfluorinated alkanoic acid and a fluorinated alkoxy acid. These methods include contacting the first solution with an anion-exchange resin to produce a second solution and a resultant anion-exchange resin having perfluorinated alkanoic acid adsorbed thereto, wherein the perfluorinated alkanoic acid is present in the first solution at a first concentration and is present in the second solution at a second concentration which is lower than the first concentration, and separating the second solution from the resultant anion-exchange resin.

Provided are methods for removing a perfluorinated alkanoic acid from solutions containing the perfluorinated alkanoic acid and a fluorinated alkoxy acid. These methods include contacting the first solution with an anion-exchange resin to produce a second solution and a resultant anion-exchange resin having perfluorinated alkanoic acid adsorbed thereto, wherein the perfluorinated alkanoic acid is present in the first solution at a first concentration and is present in the second solution at a second concentration which is lower than the first concentration, and separating the second solution from the resultant anion-exchange resin.

A process for preparing a low-molecular weight fluoropolyether containing an acid fluoride by decomposing a triflate or trifluoroacetate of a fluoropolyether having a hydroxyl group in the presence of a Lewis acid.

A process for preparing a low-molecular weight fluoropolyether containing an acid fluoride by decomposing a triflate or trifluoroacetate of a fluoropolyether having a hydroxyl group in the presence of a Lewis acid.

The present invention relates to compositions comprising compounds for use in treating, ameliorating and/or preventing neuromuscular disorders. The compounds as defined herein preferably inhibit the ClC-1 ion channel. The invention further relates to methods of treating, preventing and/or ameliorating neuromuscular disorders, by administering said composition to a person in need thereof.

The present invention relates to compositions comprising compounds for use in treating, ameliorating and/or preventing neuromuscular disorders. The compounds as defined herein preferably inhibit the ClC-1 ion channel. The invention further relates to methods of treating, preventing and/or ameliorating neuromuscular disorders, by administering said composition to a person in need thereof.